Table S1: Main characteristics of included studies.  All presented data were rounded;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
;IDU;PMID;Title;First author name;Year of recruitment;Study Type;Multicentric study;Publication year;Number of patients for the follow up;30-day all-cause readmission;30-day all-cause mortality;one-year all-cause readmission    ;one-year all-cause death    ;Number of patients for initial characteristics;Heart Failure medical history    ;Hypertension medical history    ;Diabetes mellitus medical history    ;Coronary heart disease  ischemic heart disease medical history    ;Chronic obstructive pulmonary  disease medical history    ;Atrial fibrillation medical history    ;RAASi at admission;diuretic at admission;digoxin at admission;Beta-blockers at admission;Averaged Systolic blood pressure at admission (mmHg);Averaged age at admission (years);Averaged heart rate at admission (bpm);Gender male  rate;Averaged Ejection fraction   (%)
195;9605779_Jaagosild;9605779;Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. SUPPORT Investigators. The Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments.;Jaagosild;1992;Survey;Yes;1998;1390;NA;10%;NA;38%;1390;100%;NA;33%;NA;20%;NA;64%;90%;61%;6%;NA;68;NA;62%;NA
200;9674621_Chin;9674621;Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure.;Chin;1994;Survey;No;1998;259;NA;NA;NA;23%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
201;9732905_Dahle;9732905;Impact of a nurse practitioner on the cost of managing inpatients with heart failure.;Dahle;1996;Survey;No;1998;215;15%;NA;NA;NA;215;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;54;NA;75%;NA
196;9826315_Senni;9826315;Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.;Senni;1991;Survey;Yes;1998;216;NA;NA;NA;24%;216;0%;52%;NA;40%;23%;24%;NA;NA;NA;NA;NA;77;NA;58%;NA
15;9855384_Wang;9855384;Mortality of the Institutionalized Old-Old Hospitalized With Congestive Heart Failure.;Wang;1992;Survey;No;1998;231;NA;NA;NA;63%;231;50%;38%;11%;53%;12%;32%;NA;NA;NA;NA;NA;89;NA;26%;NA
238;9892327_Senni_(a);9892327;Congestive heart failure in the community: trends in incidence and survival in a 10-year period.;Senni_(a);1981;Survey;Yes;1999;107;NA;NA;NA;28%;107;NA;48%;14%;58%;NA;NA;NA;NA;NA;NA;NA;75;NA;57%;NA
239;9892327_Senni_(b);9892327;Congestive heart failure in the community: trends in incidence and survival in a 11-year period.;Senni_(b);1991;Survey;Yes;1999;141;NA;NA;NA;23%;147;NA;54%;12%;52%;NA;NA;NA;NA;NA;NA;NA;77;NA;59%;NA
197;9930041_Cline;9930041;Cost effective management programme for heart failure reduces hospitalisation.;Cline;1992;Trial;No;1998;190;NA;NA;47%;29%;190;NA;30%;22%;53%;NA;38%;22%;72%;31%;10%;NA;76;NA;53%;34
49;10074960_Croft;10074960;Heart Failure Survival Among Older Adults in the United States : a poor prognosis for an emerging epidemic in the Medicare population.;Croft;1986;Survey;Yes;1999;170239;NA;NA;NA;33%;170239;0%;27%;16%;37%;NA;NA;NA;NA;NA;NA;NA;79;NA;42%;NA
240;10084060_Harjai;10084060;The independent effects of left ventricular ejection fraction on short-term outcomes and resource utilization following hospitalization for heart failure.;Harjai;1994;Survey;No;1999;443;7%;1%;NA;NA;443;NA;56%;NA;42%;18%;35%;NA;NA;NA;NA;NA;70;NA;55%;NA
241;10446664_Ashton_(a);10446664;Rates of health services utilization and survival in patients with heart failure in the Department of Veterans Affairs medical care system.;Ashton_(a);1992;Survey;Yes;1999;22494;NA;NA;NA;23%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
242;10446664_Ashton_(b);10446664;Rates of health services utilization and survival in patients with heart failure in the Department of Veterans Affairs medical care system.;Ashton_(b);1993;Survey;Yes;1999;26220;NA;NA;NA;21%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
243;10446664_Ashton_(c);10446664;Rates of health services utilization and survival in patients with heart failure in the Department of Veterans Affairs medical care system.;Ashton_(c);1994;Survey;Yes;1999;28783;NA;NA;NA;20%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
244;10446664_Ashton_(d);10446664;Rates of health services utilization and survival in patients with heart failure in the Department of Veterans Affairs medical care system.;Ashton_(d);1995;Survey;Yes;1999;30333;NA;NA;NA;19%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
245;10446664_Ashton_(e);10446664;Rates of health services utilization and survival in patients with heart failure in the Department of Veterans Affairs medical care system.;Ashton_(e);1996;Survey;Yes;1999;31429;NA;NA;NA;18%;31429;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;69;NA;99%;NA
246;10486417_Torp_Pedersen;10486417;Dofetilide in patients with congestive heart failure and left ventricular dysfunction, Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.;Torp_Pedersen;1994;Trial;Yes;1999;1518;NA;NA;NA;28%;1518;NA;15%;20%;67%;NA;26%;38%;NA;NA;10%;NA;70;NA;73%;NA
247;10632305_Gambassi;10632305;Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure, SAGE Study Group, Systematic Assessment of Geriatric drug use via Epidemiology.;Gambassi;1994;Survey;Yes;2000;19801;NA;NA;43%;32%;19801;NA;35%;NA;39%;NA;NA;25%;47%;76%;4%;NA;85;NA;26%;NA
198;10768897_Cowie;10768897;Survival of patients with a new diagnosis of heart failure: a population based study.;Cowie;1996;Survey;No;2000;220;NA;19%;NA;38%;220;0%;44%;16%;NA;NA;NA;NA;NA;NA;NA;140;76;100;54%;NA
290;10860090_Heller;10860090;Death and readmission in the year after hospital admission with cardiovascular disease: the Hunter Area Heart and Stroke Register.;Heller;1996;Survey;Yes;2000;778;NA;NA;35%;29%;877;NA;24%;22%;41%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
291;10895138_Hung;10895138;Epidemiology of heart failure in Hong Kong, 1997.;Hung;1997;Survey;Yes;2000;6203;NA;NA;NA;32%;6203;26%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;46%;NA
292;10973841_MacIntyre;10973841;Evidence of Improving Prognosis in Heart Failure Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995.;MacIntyre;1990;Survey;Yes;2000;66547;NA;20%;NA;44%;66547;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;47%;NA
50;11152851_Harjai;11152851;Simple clinical variables are markers of the propensity for readmission in patients hospitalized with heart failure.;Harjai;1994;Survey;No;2001;434;26%;NA;NA;NA;434;NA;56%;NA;40%;18%;35%;NA;NA;NA;NA;138;70;NA;55%;NA
13;11194290_Tsuchihashi;11194290;Clinical Characteristics and Prognosis of Hospitalized Patients With Congestive Heart Failure.;Tsuchihashi;1999;Survey;Yes;2000;230;NA;NA;35%;8%;230;38%;41%;25%;27%;NA;40%;NA;NA;NA;NA;NA;69;NA;60%;NA
51;11785996_Doughty;11785996;Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study.;Doughty;1996;Trial;No;2003;197;NA;NA;62%;22%;197;51%;51%;29%;45%;NA;32%;NA;NA;NA;NA;125;73;80;60%;32
52;11911755_Young;11911755;Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.;Young;2000;Trial;Yes;2002;489;21%;NA;NA;NA;489;NA;79%;47%;52%;NA;35%;NA;NA;NA;NA;121;61;NA;69%;NA
53;12034162_Azevedo;12034162;Effect of a heart failure clinic on survival and hospital readmission in patients discharged from acute hospital care.;Azevedo;1996;Survey;No;2002;339;NA;NA;NA;30%;339;NA;NA;19%;46%;NA;NA;NA;NA;NA;NA;131;67;88;52%;NA
303;12153371_Jong;12153371;Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart Failure.;Jong;1996;Survey;Yes;2002;38702;NA;12%;NA;33%;38702;NA;NA;NA;15%;19%;NA;NA;NA;NA;NA;NA;NA;NA;49%;NA
204;12595848_Indridason_(a);12595848;Is specialty care associated with improved survival of patients with congestive heart failure?;Indridason_(a);1992;Survey;Yes;2003;11661;NA;NA;NA;23%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;68;NA;NA;NA
205;12595848_Indridason_(b);12595848;Is specialty care associated with improved survival of patients with congestive heart failure?;Indridason_(b);1994;Survey;Yes;2003;10142;NA;NA;NA;28%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
206;12767667_Nohria;12767667;Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure.;Nohria;1998;Survey;No;2003;452;NA;NA;NA;26%;452;49%;NA;NA;NA;NA;NA;73%;80%;67%;26%;112;55;86;69%;26
207;12798837_Wright;12798837;Uptake of self-management strategies in a heart failure management programme.;Wright;1996;Trial;No;2003;197;NA;NA;NA;22%;197;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;125;NA;80;60%;32
249;14975476_Horwich;14975476;Statin Therapy Is Associated With Improved Survival in Ischemic and Non-Ischemic Heart Failure.;Horwich;2001;Survey;No;2004;550;NA;NA;NA;21%;551;NA;54%;24%;45%;NA;NA;89%;85%;NA;74%;NA;52;NA;76%;25
54;15086645_Naylor;15086645;Transitional care of older adults hospitalized with heart Failure: a randomized, controlled trial;Naylor;1999;Trial;Yes;2004;239;NA;NA;50%;10%;239;NA;53%;38%;49%;NA;35%;NA;NA;NA;NA;NA;76;NA;43%;NA
304;15150151_Luthi;15150151;Outcomes and the quality of care for patients hospitalized with heart failure.;Luthi;1999;Survey;Yes;2004;1055;13%;NA;NA;NA;1153;57%;60%;23%;33%;20%;NA;38%;NA;NA;NA;NA;75;NA;54%;37
305;15262034_Cujec_(a);15262034;The province of Alberta. Canada avoids the hospitalization epidemic for congestive heart failure patients.;Cujec_(a);1994;Survey;Yes;2004;2879;NA;NA;NA;18%;2879;NA;25%;NA;40%;NA;NA;NA;NA;NA;NA;NA;76;NA;50%;NA
306;15262034_Cujec_(b);15262034;The province of Alberta. Canada avoids the hospitalization epidemic for congestive heart failure patients.;Cujec_(b);1996;Survey;Yes;2004;2688;NA;NA;NA;22%;2688;NA;26%;NA;38%;NA;NA;NA;NA;NA;NA;NA;76;NA;48%;NA
307;15262034_Cujec_(c);15262034;The province of Alberta. Canada avoids the hospitalization epidemic for congestive heart failure patients.;Cujec_(c);1996;Survey;Yes;2004;2787;NA;NA;NA;22%;2787;NA;26%;NA;38%;NA;NA;NA;NA;NA;NA;NA;76;NA;48%;NA
308;15262034_Cujec_(d);15262034;The province of Alberta. Canada avoids the hospitalization epidemic for congestive heart failure patients.;Cujec_(d);1998;Survey;Yes;2004;2765;NA;NA;NA;21%;2765;NA;28%;NA;37%;NA;NA;NA;NA;NA;NA;NA;76;NA;49%;NA
309;15262034_Cujec_(e);15262034;The province of Alberta. Canada avoids the hospitalization epidemic for congestive heart failure patients;Cujec_(e);1998;Survey;Yes;2004;2469;NA;NA;NA;21%;2469;NA;31%;NA;37%;NA;NA;NA;NA;NA;NA;NA;76;NA;50%;NA
310;15262034_Cujec_(f);15262034;The province of Alberta. Canada avoids the hospitalization epidemic for congestive heart failure patients;Cujec_(f);2000;Survey;Yes;2004;2574;NA;NA;NA;20%;2574;NA;32%;NA;33%;NA;NA;NA;NA;NA;NA;NA;76;NA;49%;NA
55;15302008_Cotter;15302008;The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure.;Cotter;2002;Trial;No;2004;129;NA;4%;NA;NA;129;NA;NA;NA;60%;NA;NA;48%;45%;NA;29%;132;70;77;67%;28
56;15302014_Atienza;15302014;Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program;Atienza;1999;Trial;Yes;2004;338;NA;NA;39%;19%;338;NA;53%;37%;32%;NA;44%;NA;NA;NA;NA;NA;68;NA;61%;NA
57;15302017_Sosin;15302017;An 8-year follow-up study of acute admissions with heart failure in a multiethnic population.;Sosin;1994;Survey;No;2004;214;NA;NA;NA;49%;214;NA;NA;20%;54%;NA;30%;51%;NA;NA;3%;NA;74;NA;51%;NA
14;15320569_Tarantini;15320569;Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure : an effective strategy for the omplementation of beta-blockade in heart failure;Tarantini;2000;Survey;Yes;2004;164;NA;NA;30%;18%;164;NA;76%;31%;NA;30%;26%;51%;44%;27%;NA;125;76;78;61%;30
259;15470646_Shahar;15470646;Hospitalized Heart Failure: Rates and Long-Term Mortality.;Shahar;1995;Survey;Yes;2004;2887;NA;NA;NA;34%;2887;64%;65%;34%;52%;NA;NA;NA;NA;NA;NA;NA;NA;NA;51%;NA
58;15492340_DeBusk;15492340;Care management for low-risk patients with heart failure: a randomized, controlled trial;DeBusk;2000;Trial;Yes;2004;462;NA;NA;50%;11%;462;59%;65%;33%;51%;17%;NA;NA;NA;NA;NA;NA;72;NA;51%;NA
59;15820161_Sheppard;15820161;Effect of gender on treatment, resource utilization, and outcomes in congestive heart failure in Quebec, Canada.;Sheppard;2000;Survey;No;2005;32639;NA;NA;16%;NA;32639;NA;NA;33%;22%;31%;NA;NA;NA;NA;NA;NA;76;NA;49%;NA
60;15921809_Rudiger;15921809;Acute heart failure: clinical presentation, one-year mortality and prognostic factors.;Rudiger;2002;Survey;Yes;2005;312;NA;11%;NA;29%;312;NA;54%;32%;NA;NA;29%;NA;NA;NA;NA;140;73;90;56%;NA
61;15948086_Dunagan;15948086;Randomized trial of a nurse-administered, telephone-based disease management program for patients with heart failure.;Dunagan;1999;Trial;No;2005;151;NA;NA;70%;16%;151;NA;NA;NA;NA;NA;NA;71%;NA;NA;NA;NA;70;NA;44%;NA
62;16183441_Peacock;16183441;Observation unit treatment of heart failure with nesiritide: results from the proaction trial.;Peacock;2002;Trial;Yes;2005;237;16%;3%;NA;NA;237;NA;NA;NA;NA;NA;NA;57%;78%;41%;46%;NA;66;NA;60%;NA
250;16186261_Eurich;16186261;Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure.;Eurich;1994;Survey;Yes;2005;1833;NA;NA;51%;18%;1833;100%;NA;100%;15%;NA;NA;70%;79%;NA;39%;NA;72;NA;57%;NA
63;16204662_Binanay;16204662;Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.;Binanay;2002;Trial;Yes;2005;433;NA;5%;NA;NA;433;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;106;56;82;74%;20
64;16216863_Grigorian_Shamagian;16216863;Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function.;Grigorian_Shamagian;2001;Survey;No;2005;205;NA;NA;NA;18%;210;NA;69%;21%;NA;NA;37%;NA;NA;NA;NA;NA;73;NA;48%;NA
202;16219900_Skrepnek;16219900;Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.;Skrepnek;1998;Survey;Yes;2005;1903;NA;NA;61%;NA;1903;NA;NA;25%;NA;NA;24%;NA;NA;NA;NA;NA;69;NA;49%;NA
65;16246989_Kosiborod;16246989;Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.;Kosiborod;2000;Survey;Yes;2005;50405;NA;NA;NA;36%;50405;NA;66%;41%;30%;34%;30%;43%;74%;41%;29%;147;79;90;41%;NA
66;16516552_Zannad;16516552;Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study.;Zannad;2001;Survey;Yes;2006;581;NA;27%;NA;46%;581;35%;60%;27%;46%;NA;25%;42%;52%;19%;26%;126;73;NA;59%;38
67;16618450_Formiga;16618450;Anemia in new-onset congestive heart failure inpatients admitted for acute decompensation.;Formiga;2002;Survey;No;2006;103;NA;NA;NA;23%;103;0%;NA;31%;NA;NA;34%;NA;NA;NA;NA;158;79;96;47%;NA
68;16624834_Cowie;16624834;"Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure; results of the prospective outcomes study in heart failure (POSH).";Cowie;2002;Survey;Yes;2006;299;20%;8%;NA;NA;299;100%;47%;33%;51%;NA;41%;NA;NA;NA;62%;NA;68;NA;74%;28
270;16735672_McAlister;16735672;Aspirin Use and Outcomes in a Community-Based Cohort of 7352 Patients Discharged After First Hospitalization for Heart Failure.;McAlister;2000;Survey;Yes;2006;7352;NA;NA;60%;26%;7352;NA;49%;35%;NA;17%;29%;NA;NA;NA;NA;151;75;95;50%;41
251;16828634_Kosiborod_(a);16828634;National Trends in Outcomes Among Elderly Patients with Heart Failure.;Kosiborod_(a);1992;Survey;Yes;2006;483560;10%;11%;NA;33%;483560;16%;27%;26%;NA;27%;NA;NA;NA;NA;NA;NA;79;NA;43%;NA
252;16828634_Kosiborod_(b);16828634;National Trends in Outcomes Among Elderly Patients with Heart Failure.;Kosiborod_(b);1993;Survey;Yes;2006;509549;12%;11%;NA;34%;509549;32%;30%;29%;NA;31%;NA;NA;NA;NA;NA;NA;79;NA;42%;NA
253;16828634_Kosiborod_(c);16828634;National Trends in Outcomes Among Elderly Patients with Heart Failure.;Kosiborod_(c);1994;Survey;Yes;2006;509245;12%;11%;NA;32%;509245;33%;35%;31%;NA;32%;NA;NA;NA;NA;NA;NA;79;NA;42%;NA
254;16828634_Kosiborod_(d);16828634;National Trends in Outcomes Among Elderly Patients with Heart Failure.;Kosiborod_(d);1995;Survey;Yes;2006;510529;13%;11%;NA;32%;510529;34%;38%;33%;NA;33%;NA;NA;NA;NA;NA;NA;80;NA;41%;NA
255;16828634_Kosiborod_(e);16828634;National Trends in Outcomes Among Elderly Patients with Heart Failure.;Kosiborod_(e);1996;Survey;Yes;2006;505661;13%;10%;NA;31%;505661;34%;40%;34%;NA;34%;NA;NA;NA;NA;NA;NA;80;NA;41%;NA
256;16828634_Kosiborod_(f);16828634;National Trends in Outcomes Among Elderly Patients with Heart Failure.;Kosiborod_(f);1997;Survey;Yes;2006;507986;13%;10%;NA;32%;507986;35%;41%;35%;NA;35%;NA;NA;NA;NA;NA;NA;80;NA;41%;NA
257;16828634_Kosiborod_(g);16828634;National Trends in Outcomes Among Elderly Patients with Heart Failure.;Kosiborod_(g);1998;Survey;Yes;2006;436257;14%;10%;NA;32%;436257;36%;42%;36%;NA;36%;NA;NA;NA;NA;NA;NA;80;NA;41%;NA
258;16828634_Kosiborod_(h);16828634;National Trends in Outcomes Among Elderly Patients with Heart Failure.;Kosiborod_(h);1999;Survey;Yes;2006;494733;14%;10%;NA;32%;494733;37%;44%;37%;NA;36%;NA;NA;NA;NA;NA;NA;80;NA;11%;NA
69;16863484_Arnold;16863484;Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.;Arnold;2002;Survey;Yes;2006;2130;6%;NA;NA;NA;2130;100%;40%;32%;53%;NA;31%;64%;96%;57%;54%;NA;63;NA;65%;NA
70;17074775_Mitrovic;17074775;Haemodynamic and clinical effects of ularitide in decompensated heart failure.;Mitrovic;2004;Trial;Yes;2006;221;NA;5%;NA;NA;221;100%;NA;36%;NA;NA;NA;82%;94%;60%;73%;126;60;77;78%;NA
71;17127708_Siirila_Waris;17127708;Characteristics outcomes and predictors of 1-year mortality in patients hospitalized for acute heart failure.;Siirila_Waris;2004;Survey;Yes;2006;620;NA;NA;NA;28%;620;51%;55%;32%;55%;13%;27%;NA;NA;NA;63%;147;75;NA;50%;NA
72;17384437_Konstam;17384437;Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure.;Konstam;2004;Trial;Yes;2007;4133;NA;NA;NA;26%;4133;79%;71%;39%;NA;NA;43%;84%;97%;NA;70%;121;66;NA;74%;28
73;17449141_Auble;17449141;Comparison of four clinical prediction rules for estimating risk in heart failure.;Auble;1999;Survey;Yes;2007;33533;NA;8%;NA;NA;33533;63%;NA;40%;61%;NA;NA;NA;NA;NA;NA;148;75;90;44%;NA
261;17482692_Miller;17482692;Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.;Miller;2003;Survey;No;2008;167;NA;NA;NA;42%;167;NA;59%;49%;62%;NA;NA;NA;NA;NA;NA;112;71;79;65%;30
260;17491211_Garty;17491211;The Management, Early and One Year Outcome in Hospitalized Patients with Heart Failure: A National Heart Failure Survey in Israel â€šHFSIS 2003.;Garty;2004;Survey;Yes;2007;4102;NA;8%;NA;28%;4102;NA;75%;50%;82%;20%;33%;NA;NA;NA;NA;NA;73;NA;57%;NA
208;17643574_Setoguchi;17643574;Repeated hospitalizations predict mortality in the community population with heart failure.;Setoguchi;2002;Survey;Yes;2007;14374;NA;12%;NA;34%;14374;NA;71%;36%;47%;24%;36%;NA;NA;NA;NA;NA;77;NA;54%;NA
74;17664189_Berry;17664189;Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure.;Berry;2000;Survey;No;2008;454;NA;NA;NA;29%;454;NA;NA;NA;37%;11%;30%;71%;86%;21%;33%;NA;72;NA;49%;NA
209;17670760_Tabrizi;17670760;Influence of left bundle branch block on long-term mortality in a population with heart failure.;Tabrizi;1999;Survey;Yes;2007;21685;NA;NA;NA;29%;21685;50%;37%;28%;NA;12%;35%;41%;65%;23%;45%;NA;75;NA;55%;NA
75;17936154_Givertz;17936154;The effects of KW-3902, an adenosine A1-receptor antagonist  on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.;Givertz;2002;Trial;Yes;2007;146;NA;7%;NA;NA;146;NA;NA;NA;51%;NA;NA;85%;NA;33%;83%;124;67;78;68%;32
76;17986694_McMurray;17986694;Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.;McMurray;2004;Trial;Yes;2007;1435;NA;4%;NA;NA;1435;73%;80%;48%;71%;NA;37%;53%;29%;22%;47%;132;70;82;60%;29
294;18054808_Kubler;18054808;Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.;Kubler;2002;Survey;No;2007;103;NA;NA;NA;28%;103;NA;NA;33%;NA;9%;31%;NA;NA;NA;NA;124;64;94;86%;28
77;18156618_Tribouilloy;18156618;Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study.;Tribouilloy;2000;Survey;Yes;2008;662;NA;NA;NA;24%;662;0%;62%;26%;13%;21%;34%;NA;NA;NA;NA;NA;74;NA;54%;51
78;18280788_Ezekowitz_(a);18280788;Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure.;Ezekowitz_(a);2000;Survey;Yes;2008;3627;19%;3%;58%;20%;3627;21%;37%;23%;27%;NA;5%;80%;86%;42%;50%;NA;79;NA;50%;NA
79;18280788_Ezekowitz_(b);18280788;Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure.;Ezekowitz_(b);2000;Survey;Yes;2008;6788;21%;11%;60%;34%;6788;23%;37%;25%;31%;NA;27%;78%;81%;44%;49%;NA;80;NA;48%;NA
80;18304693_Miller;18304693;Acutely Decompensated Heart Failure in a County Emergency Department: A Double-Blind Randomized Controlled Comparison of Nesiritide Versus Placebo Treatment;Miller;2004;Trial;No;2008;101;41%;5%;NA;NA;101;NA;86%;49%;NA;12%;9%;NA;NA;NA;NA;149;56;92;66%;NA
81;18534276_Gheorghiade;18534276;Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.;Gheorghiade;2006;Trial;Yes;2008;120;NA;2%;NA;NA;120;NA;NA;17%;64%;NA;NA;92%;90%;8%;98%;116;55;73;88%;27
82;18614781_Gray;18614781;Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema;Gray;2005;Trial;Yes;2008;1069;NA;16%;NA;NA;1069;45%;55%;31%;63%;18%;NA;NA;NA;NA;NA;161;78;113;43%;NA
234;18722158_Paul;18722158;Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction.;Paul;2003;Survey;No;2008;133;26%;6%;NA;NA;133;72%;NA;NA;57%;NA;NA;56%;NA;27%;27%;NA;74;NA;53%;43
311;18931450_Kawashiro;18931450;Clinical Characteristics and Outcome of Hospitalized Patients With Congestive Heart Failure.;Kawashiro;2002;Survey;Yes;2008;3169;NA;NA;NA;11%;3169;34%;54%;31%;34%;NA;36%;NA;NA;NA;NA;NA;70;NA;59%;42
312;18954847_Gotsman;18954847;Clinical Outcome of Patients with Heart Failure and Preserved Left Ventricular Function.;Gotsman;2002;Survey;No;2008;289;NA;NA;70%;28%;289;NA;56%;42%;69%;27%;33%;NA;NA;NA;NA;NA;73;NA;53%;NA
313;19064833_Curtis_(a);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(a);2001;Survey;Yes;2008;498176;NA;12%;NA;37%;498176;NA;64%;42%;NA;42%;NA;NA;NA;NA;NA;NA;80;NA;41%;NA
314;19064833_Curtis_(b);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(b);2002;Survey;Yes;2008;503054;NA;12%;NA;37%;503054;NA;67%;43%;NA;43%;NA;NA;NA;NA;NA;NA;80;NA;41%;NA
315;19064833_Curtis_(c);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(c);2003;Survey;Yes;2008;520094;NA;11%;NA;37%;520094;NA;68%;43%;NA;43%;NA;NA;NA;NA;NA;NA;80;NA;42%;NA
316;19064833_Curtis_(d);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(d);2004;Survey;Yes;2008;519713;NA;11%;NA;36%;519713;NA;69%;43%;NA;43%;NA;NA;NA;NA;NA;NA;80;NA;42%;NA
317;19064833_Curtis_(e);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(e);2005;Survey;Yes;2008;499801;NA;11%;NA;NA;499801;NA;67%;42%;NA;41%;NA;NA;NA;NA;NA;NA;80;NA;43%;NA
318;19064833_Curtis_(f);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(f);2001;Survey;Yes;2008;473058;23%;NA;67%;NA;498176;NA;64%;42%;NA;42%;NA;NA;NA;NA;NA;NA;80;NA;41%;NA
319;19064833_Curtis_(g);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(g);2002;Survey;Yes;2008;478411;23%;NA;67%;NA;503054;NA;67%;43%;NA;43%;NA;NA;NA;NA;NA;NA;80;NA;41%;NA
320;19064833_Curtis_(h);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(h);2003;Survey;Yes;2008;496553;23%;NA;67%;NA;520094;NA;68%;43%;NA;43%;NA;NA;NA;NA;NA;NA;80;NA;42%;NA
321;19064833_Curtis_(i);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(i);2004;Survey;Yes;2008;497292;23%;NA;67%;NA;519713;NA;69%;43%;NA;43%;NA;NA;NA;NA;NA;NA;80;NA;42%;NA
322;19064833_Curtis_(j);19064833;Early and Long-term Outcomes of Heart Failure in Elderly Persons. 2001-2005.;Curtis_(j);2005;Survey;Yes;2008;479401;22%;NA;NA;NA;499801;NA;67%;42%;NA;41%;NA;NA;NA;NA;NA;NA;80;NA;43%;NA
203;19157162_Roik;19157162;Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report.;Roik;2002;Survey;No;2008;146;NA;1%;NA;9%;146;NA;71%;21%;NA;7%;35%;81%;64%;8%;85%;NA;68;NA;53%;53
335;19185638_Auble;19185638;Differences in initial severity of illness between black and white emergency department patients hospitalized with heart failure.;Auble;2004;Survey;Yes;2008;8668;NA;9%;NA;NA;8668;70%;NA;38%;10%;34%;NA;NA;NA;NA;NA;140;76;82;43%;NA
210;19219395_Gorelik;19219395;Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure.;Gorelik;2004;Survey;No;2009;473;NA;NA;NA;23%;473;NA;79%;47%;76%;26%;22%;NA;NA;NA;NA;NA;73;NA;57%;41
83;19233107_Assyag_(a);19233107;RESICARD: East Paris network for the management of heart failure: Absence of effect on mortality and rehospitalization in patients with severe heart failure admitted following severe decompensation.;Assyag_(a);2002;Trial;Yes;2009;211;NA;NA;51%;22%;211;20%;NA;NA;NA;NA;NA;43%;54%;NA;26%;NA;74;NA;57%;NA
84;19233107_Assyag_(b);19233107;RESICARD: East Paris network for the management of heart failure: Absence of effect on mortality and rehospitalization in patients with severe heart failure admitted following severe decompensation.;Assyag_(b);2002;Trial;Yes;2009;218;NA;NA;55%;19%;218;15%;NA;NA;NA;NA;NA;51%;58%;NA;36%;NA;72;NA;60%;NA
235;19234309_Gustafsson;19234309;Incidence and predictors of hospitalization or death in patients managed in multidisciplinary heart failure clinics.;Gustafsson;2004;Survey;Yes;2009;4012;NA;NA;39%;10%;4012;NA;NA;17%;59%;NA;NA;79%;67%;23%;69%;129;NA;75;71%;NA
85;19398077_Konishi;19398077;Clinical Characteristics of Acute Decompensated Heart Failure With Rapid Onset of Symptoms.;Konishi;2006;Survey;No;2009;130;NA;NA;21%;5%;130;40%;73%;32%;33%;NA;23%;24%;54%;11%;26%;150;73;97;59%;41
86;19522957_Styron;19522957;Outcomes associated with nesiritide administration for acute decompensated heart failure in the emergency department observation unit: a single center experience.;Styron;2003;Survey;No;2009;595;14%;2%;NA;NA;595;73%;77%;44%;50%;13%;25%;NA;NA;NA;NA;145;70;83;53%;NA
87;19536386_Richter;19536386;Practice patterns and outcomes in patients presenting to the emergency department with acute heart failure.;Richter;2002;Survey;Yes;2009;448;20%;3%;NA;NA;448;63%;55%;34%;39%;28%;28%;70%;58%;24%;37%;NA;75;NA;55%;NA
88;19627289_Zareba;19627289;Comparison of Acute Electrocardiographic Presentation in Patients With Diastolic vs Systolic Heart Failure.;Zareba;2005;Survey;No;2009;241;20%;11%;NA;NA;241;NA;NA;NA;45%;NA;NA;NA;NA;NA;NA;138;69;NA;61%;37
89;19808351_Singer;19808351;Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II).;Singer;2005;Trial;Yes;2009;472;22%;5%;NA;NA;472;NA;NA;NA;NA;NA;NA;66%;92%;NA;72%;148;64;88;51%;NA
1;19932515_Cotter;19932515;Patterns of leukocyte counts on admissions for acute heart failure - presentation and outcome - results from a community based registry.;Cotter;2004;Survey;No;2009;310;NA;7%;NA;NA;310;NA;72%;51%;70%;NA;29%;NA;NA;NA;NA;164;75;93;51%;42
90;20071655_Teng_(a);20071655;Heart failure: incidence, case fatality, and hospitalization rates in Western Australia between 1990 and 2005.;Teng_(a);1992;Survey;Yes;2010;5189;NA;12%;NA;31%;5189;NA;33%;18%;34%;23%;18%;NA;NA;NA;NA;NA;76;NA;51%;NA
91;20071655_Teng_(b);20071655;Heart failure: incidence, case fatality, and hospitalization rates in Western Australia between 1990 and 2005.;Teng_(b);1996;Survey;Yes;2010;4716;NA;9%;NA;28%;4716;NA;46%;23%;36%;29%;27%;NA;NA;NA;NA;NA;76;NA;51%;NA
92;20071655_Teng_(c);20071655;Heart failure: incidence, case fatality, and hospitalization rates in Western Australia between 1990 and 2005.;Teng_(c);2000;Survey;Yes;2010;4625;NA;9%;NA;25%;4625;NA;50%;26%;32%;28%;31%;NA;NA;NA;NA;NA;77;NA;51%;NA
93;20071655_Teng_(d);20071655;Heart failure: incidence, case fatality, and hospitalization rates in Western Australia between 1990 and 2005.;Teng_(d);2004;Survey;Yes;2010;4812;NA;8%;NA;23%;4812;NA;48%;27%;29%;24%;34%;NA;NA;NA;NA;NA;77;NA;53%;NA
94;20156940_Harjola;20156940;Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure.;Harjola;2004;Survey;Yes;2010;2475;NA;NA;NA;22%;2981;62%;62%;33%;33%;19%;39%;NA;NA;NA;NA;138;72;NA;62%;38
95;20196990_Belziti;20196990;Worsening Renal Function in Patients Admitted With Acute Decompensated Heart Failure: Incidence, Risk Factors and Prognostic Implications.;Belziti;2006;Survey;No;2010;200;NA;NA;17%;19%;200;NA;NA;24%;38%;12%;21%;72%;98%;20%;71%;118;78;NA;57%;NA
217;20370326_Baggish;20370326;New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis.;Baggish;2004;Survey;Yes;2010;720;NA;NA;NA;31%;720;52%;64%;NA;53%;29%;35%;NA;60%;NA;NA;NA;75;93;51%;NA
96;20498608_Davidson;20498608;Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?;Davidson;2001;Trial;No;2010;105;NA;NA;56%;14%;105;NA;74%;27%;NA;12%;53%;78%;NA;38%;52%;NA;73;NA;62%;NA
97;20550660_Di_Somma;20550660;In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.;Di_Somma;2006;Survey;Yes;2010;247;NA;0%;NA;NA;247;NA;70%;29%;45%;NA;44%;NA;NA;NA;NA;143;76;91;48%;45
295;20808904_Novack;20808904;Routine Laboratory Results and Thirty Day and One-Year Mortality Risk Following Hospitalization with Acute Decompensated Heart Failure.;Novack;2003;Survey;Yes;2010;8246;NA;9%;NA;29%;8246;NA;59%;38%;61%;14%;36%;60%;75%;15%;57%;NA;76;NA;52%;NA
98;20825901_Frontin;20825901;Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study.;Frontin;2007;Trial;No;2011;122;NA;11%;NA;NA;122;NA;57%;NA;25%;NA;12%;NA;NA;NA;NA;167;79;109;43%;NA
99;20825913_Peacock;20825913;Hypertensive heart failure: patient characteristics, treatment, and outcomes.;Peacock;2008;Survey;Yes;2011;302;26%;5%;NA;NA;302;51%;95%;44%;NA;17%;NA;49%;42%;NA;55%;210;59;NA;52%;50
296;20851294_Kommuri;20851294;Six-minute Walk Distance Predicts 30-Day Readmission in Hospitalized Heart Failure Patients.;Kommuri;2005;Survey;No;2010;210;NA;3%;NA;NA;210;NA;76%;40%;67%;26%;NA;82%;84%;NA;73%;130;67;84;28%;NA
323;20927502_Luers;20927502;Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure.;Luers;2003;Survey;No;2010;116;NA;33%;NA;NA;116;NA;71%;34%;33%;NA;NA;39%;56%;NA;41%;NA;70;NA;61%;41
324;20935009_Ballard;20935009;Impact of a standardized heart failure order set on mortality, readmission and quality and costs of care.;Ballard;2008;Survey;Yes;2010;2633;13%;7%;NA;NA;2633;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;69;NA;25%;NA
100;20940649_Amarasingham;20940649;An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data.;Amarasingham;2008;Survey;No;2010;1372;24%;3%;NA;NA;1372;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;57;NA;61%;NA
333;20969758_Vaartjes;20969758;Age- and gender-specific risk of death after first hospitalization for heart failure.;Vaartjes;1998;Survey;Yes;2010;29053;NA;18%;NA;37%;29053;NA;NA;18%;18%;NA;NA;NA;NA;NA;NA;NA;76;NA;50%;NA
101;21080863_Svensson;21080863;Change in blood pressure during hospitalisation for acute heart failure predicts mortality.;Svensson;2004;Survey;No;2010;208;NA;NA;NA;33%;208;17%;22%;24%;47%;NA;43%;35%;68%;13%;59%;145;77;NA;50%;NA
218;21296322_Michtalik;21296322;Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.;Michtalik;2006;Survey;Yes;2011;217;13%;NA;40%;22%;217;NA;70%;48%;43%;23%;30%;NA;NA;NA;NA;NA;63;NA;50%;30
219;21467294_Shah;21467294;Characteristics and outcomes of very elderly patients after first hospitalization for heart failure.;Shah;2004;Survey;Yes;2011;21397;16%;10%;NA;37%;21397;51%;74%;26%;40%;25%;27%;NA;NA;NA;NA;NA;84;NA;97%;NA
102;21477872_Delgado_Parada;21477872;Mortality and functional evolution at one year after hospital admission due to heart failure (HF) in elderly patients.;Delgado_Parada;2007;Survey;No;2011;159;NA;NA;NA;33%;159;NA;80%;29%;NA;27%;55%;57%;92%;40%;21%;NA;85;NA;41%;49
334;21508417_Kaul;21508417;Ethnic differences in 1-year mortality among patients hospitalised with heart failure.;Kaul;2002;Survey;Yes;2010;54208;NA;NA;NA;31%;54208;NA;64%;30%;57%;41%;34%;NA;NA;NA;NA;NA;76;NA;49%;NA
103;21641150_Karasek;21641150;Acute heart failure registry from high-volume university hospital ED: comparing European and US data.;Karasek;2005;Survey;No;2012;199;NA;21%;NA;NA;202;22%;59%;45%;NA;NA;NA;NA;NA;NA;NA;139;75;101;51%;38
104;21697728_Fedele;21697728;Cost-effectiveness of Levosimendan in Patients With Acute Heart Failure.;Fedele;2008;Survey;No;2011;292;NA;4%;11%;NA;292;NA;NA;28%;NA;NA;NA;NA;NA;NA;NA;NA;67;NA;78%;NA
105;21732835_O_Connor;21732835;Effect of Nesiritide in Patients with Acute Decompensated Heart Failure.;O_Connor;2008;Trial;Yes;2011;7007;NA;4%;NA;NA;7007;39%;72%;NA;60%;NA;38%;61%;95%;27%;58%;124;67;82;66%;NA
106;21799419_Miro_(a);21799419;Multicentric investigation of survival after Spanish emergency department discharge for acute heart failure.;Miro_(a);2008;Survey;Yes;2012;543;NA;3%;NA;NA;543;69%;81%;44%;32%;NA;48%;57%;NA;NA;34%;NA;NA;NA;47%;NA
107;21799419_Miro_(b);21799419;Multicentric investigation of survival after Spanish emergency department discharge for acute heart failure.;Miro_(b);2008;Survey;Yes;2012;1116;NA;5%;NA;NA;1116;72%;82%;42%;31%;NA;46%;58%;NA;NA;29%;NA;NA;NA;47%;NA
108;21906204_Peacock;21906204;Short-term mortality risk in emergency department acute heart failure.;Peacock;2008;Survey;No;2011;466;NA;7%;NA;NA;466;70%;80%;39%;50%;22%;NA;NA;NA;NA;NA;141;71;88;59%;40
109;21984121_Arenja;21984121;Risk stratification for 1-year mortality in acute heart failure.;Arenja;2004;Survey;No;2011;610;NA;NA;NA;33%;610;NA;71%;30%;NA;25%;NA;76%;82%;9%;61%;139;82;91;54%;NA
110;22082878_Cikrikcioglu;22082878;Absolute blood eosinophil count and 1-year mortality risk following hospitalization with acute heart failure.;Cikrikcioglu;2009;Survey;No;2012;176;NA;NA;NA;36%;176;68%;NA;NA;NA;NA;NA;37%;77%;22%;30%;NA;69;NA;52%;NA
111;22158534_Hsiao;22158534;Validating the acute heart failure index for patients presenting to the emergency department with decompensated heart failure.;Hsiao;2008;Survey;No;2012;259;NA;5%;NA;NA;259;NA;NA;45%;56%;NA;NA;NA;NA;NA;NA;NA;68;NA;51%;NA
268;22158777_Liu;22158777;Albumin levels predict survival in patients with heart failure and preserved ejection fraction.;Liu;2008;Survey;No;2012;576;NA;NA;NA;23%;576;38%;65%;41%;25%;11%;28%;52%;71%;13%;41%;154;77;NA;36%;64
112;22167320_Metra;22167320;Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.;Metra;2007;Survey;No;2012;593;NA;NA;NA;13%;594;66%;53%;35%;NA;20%;36%;76%;99%;NA;60%;129;69;82;74%;33
267;22343264_Singh;22343264;Comparison of Renal Predictors for In-Hospital and PostDischarge Mortality after Hospitalized Heart Failure.;Singh;2004;Survey;Yes;2012;6132;NA;NA;NA;27%;6132;NA;47%;28%;25%;NA;20%;NA;NA;NA;NA;NA;68;NA;49%;38
266;22371525_Lynga;22371525;Weight monitoring in patients with severe heart failure (WISH), A randomized controlled trial.;Lynga;2007;Trial;Yes;2012;319;NA;NA;51%;4%;319;76%;NA;26%;47%;NA;53%;66%;NA;22%;92%;NA;74;NA;75%;NA
265;22395196_Fu;22395196;Efficacy and safety of a modified dosage regimen of nesiritide in patients older than 75 years with acute heart failure.;Fu;2010;Trial;No;2012;140;NA;11%;NA;NA;140;NA;NA;NA;95%;NA;NA;55%;93%;NA;75%;NA;87;NA;91%;NA
113;22747708_Zhou;22747708;Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes.;Zhou;2006;Survey;No;2012;885;NA;NA;23%;NA;1005;NA;48%;37%;50%;NA;29%;NA;NA;NA;NA;130;63;NA;62%;NA
114;22778174_Erdmann;22778174;Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure.;Erdmann;2008;Trial;Yes;2012;148;8%;3%;NA;NA;148;100%;NA;26%;NA;NA;NA;87%;95%;NA;82%;123;62;80;85%;NA
262;22819429_Wang;22819429;Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration.;Wang;2008;Survey;Yes;2012;198640;4%;1%;24%;7%;198460;NA;81%;50%;61%;31%;29%;NA;NA;NA;NA;NA;NA;NA;98%;NA
115;22858077_Konishi;22858077;Progression of hyponatremia is associated with increased cardiac mortality in patients hospitalized for acute decompensated heart failure.;Konishi;2009;Survey;No;2012;531;NA;NA;NA;12%;531;24%;74%;33%;65%;2%;23%;NA;NA;NA;NA;142;67;87;75%;40
211;22908143_Yeung_(a);22908143;Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.;Yeung_(a);1998;Survey;Yes;2012;20039;17%;16%;49%;34%;20039;NA;36%;26%;54%;25%;23%;NA;NA;NA;NA;NA;76;NA;49%;NA
212;22908143_Yeung_(b);22908143;Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.;Yeung_(b);2000;Survey;Yes;2012;21418;16%;17%;48%;34%;21418;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
213;22908143_Yeung_(c);22908143;Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.;Yeung_(c);2002;Survey;Yes;2012;22000;16%;16%;46%;33%;22000;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
214;22908143_Yeung_(d);22908143;Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.;Yeung_(d);2004;Survey;Yes;2012;18920;16%;16%;46%;34%;18920;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
215;22908143_Yeung_(e);22908143;Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.;Yeung_(e);2006;Survey;Yes;2012;17906;16%;17%;45%;34%;17906;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
216;22908143_Yeung_(f);22908143;Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.;Yeung_(f);2008;Survey;Yes;2012;17262;16%;16%;45%;35%;17262;NA;47%;35%;44%;23%;30%;NA;NA;NA;NA;NA;78;NA;48%;NA
116;23054408_Vaclavik;23054408;ECG in patients with acute heart failure can predict in-hospital and long-term mortality.;Vaclavik;2008;Survey;Yes;2014;3627;NA;NA;NA;25%;4153;42%;73%;43%;NA;16%;NA;48%;55%;17%;51%;135;74;90;58%;37
117;23141816_Teerlink;23141816;Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.;Teerlink;2010;Trial;Yes;2013;1161;NA;3%;NA;NA;1161;34%;86%;48%;52%;16%;52%;54%;NA;20%;68%;142;72;80;63%;39
248;23224919_Camara;23224919;Role of biological and non biological factors in congestive heart failure mortality: PREDICE-SCORE: a clinical prediction rule.;Camara;2004;Survey;Yes;2012;600;NA;NA;NA;16%;600;NA;NA;NA;16%;NA;30%;55%;73%;25%;31%;143;74;NA;49%;NA
220;23336425_Barsuk;23336425;A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure.;Barsuk;2010;Survey;No;2013;596;28%;2%;NA;NA;596;NA;NA;NA;NA;NA;NA;46%;NA;17%;83%;135;67;NA;51%;NA
118;23476054_Tavazzi;23476054;Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry.;Tavazzi;2008;Survey;Yes;2013;1855;NA;NA;31%;24%;1855;46%;58%;40%;NA;30%;38%;NA;NA;NA;NA;134;72;90;60%;NA
119;23478743_Gheorghiade;23478743;Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.;Gheorghiade;2010;Trial;Yes;2013;1615;NA;NA;NA;18%;1615;67%;76%;41%;55%;19%;42%;84%;96%;39%;83%;123;65;78;77%;28
120;23537547_Maggioni;23537547;EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure. Pilot Survey (ESC-HF Pilot);Maggioni;2010;Survey;Yes;2013;1892;NA;NA;44%;17%;1892;NA;62%;35%;NA;15%;44%;77%;NA;NA;79%;133;69;88;63%;38
199;23539659_Rossi;23539659;Importance of the time of initiation of mineralocorticoid receptor antagonists on risk of mortality in patients with heart failure.;Rossi;2009;Survey;No;2015;689;NA;NA;NA;10%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;73;NA;NA;35
224;23570474_Stiell;23570474;A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events.;Stiell;2008;Survey;Yes;2013;342;NA;1%;NA;NA;559;66%;63%;39%;NA;15%;37%;46%;74%;14%;65%;142;76;82;56%;NA
273;23573279_Desmoulin;23573279;Metabonomics Analysis of Plasma Reveals the Lactate to Cholesterol Ratio as an Independent Prognostic Factor of Short-Term Mortality in Acute Heart Failure.;Desmoulin;2008;Survey;No;2013;126;NA;22%;NA;NA;126;NA;58%;38%;52%;NA;NA;32%;91%;NA;33%;NA;69;91;61%;35
121;23759684_Golcuk;23759684;Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure;Golcuk;2008;Survey;No;2013;100;NA;21%;NA;53%;100;NA;66%;22%;40%;NA;NA;NA;NA;NA;NA;145;71;101;50%;NA
288;23801998_Roy;23801998;A Comparison of Traditional and Novel Definitions (RIFLE. AKIN. and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure.;Roy;2006;Survey;No;2013;637;NA;4%;NA;8%;635;NA;NA;24%;NA;NA;46%;NA;NA;NA;NA;NA;65;NA;71%;25
122;23910589_Manzano_Fernandez;23910589;Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure;Manzano_Fernandez;2008;Survey;Yes;2012;526;NA;NA;NA;25%;526;NA;82%;51%;NA;27%;58%;NA;NA;NA;NA;144;76;96;45%;52
263;24093516_Nakano_(a);24093516;Trends in quality of care among patients with incident heart failure in Denmark 2003 2010: a nationwide cohort study.;Nakano_(a);2003;Survey;Yes;2013;1624;NA;NA;NA;21%;1624;NA;NA;NA;NA;NA;NA;92%;NA;NA;73%;NA;NA;NA;NA;NA
264;24093516_Nakano_(b);24093516;Trends in quality of care among patients with incident heart failure in Denmark 2003 2010: a nationwide cohort study.;Nakano_(b);2006;Survey;Yes;2013;3809;NA;NA;NA;13%;3809;NA;NA;NA;NA;NA;NA;93%;NA;NA;88%;NA;NA;NA;NA;NA
2;24125104_Aronson;24125104;Pulmonary Hypertension, Right Ventricular Function, and Clinical Outcome in Acute Decompensated Heart Failure.;Aronson;2010;Survey;No;2013;326;NA;NA;NA;34%;324;NA;98%;46%;57%;NA;42%;65%;87%;9%;70%;NA;64;NA;44%;NA
271;24207066_Carrasco_Sanchez;24207066;Predidctive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction.;Carrasco_Sanchez;2010;Survey;Yes;2013;419;NA;NA;NA;31%;419;NA;84%;49%;NA;55%;55%;88%;93%;NA;46%;NA;76;NA;39%;NA
123;24477201_Di_Somma;24477201;Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency department.;Di_Somma;2011;Survey;Yes;2014;270;26%;10%;NA;NA;270;52%;79%;37%;41%;32%;32%;NA;NA;NA;NA;140;77;86;53%;NA
124;24485633_Triposkiadis;24485633;Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.;Triposkiadis;2010;Trial;Yes;2014;161;NA;NA;NA;35%;161;66%;82%;48%;52%;NA;41%;65%;75%;13%;61%;166;78;90;54%;32
40;24655702_Peacock;24655702;Clevidipine in Acute Heart Failure: Results of the PRONTO Study.;Peacock;2010;Trial;Yes;2014;104;16%;NA;NA;NA;85;NA;97%;52%;40%;22%;NA;NA;NA;NA;NA;NA;61;NA;49%;45
39;24662470_Tuppin;24662470;Two-year outcome of patients after a first hospitalization for heart failure: A national observational study.;Tuppin;2009;Survey;Yes;2014;69958;5%;11%;16%;29%;69958;NA;NA;NA;NA;NA;NA;56%;60%;NA;39%;NA;78;NA;52%;NA
38;24687697_Whittaker;24687697;Patient and process factors associated with all-cause 30-day readmission among patients with heart failure.;Whittaker;2010;Survey;No;2015;239;21%;NA;NA;NA;239;NA;49%;37%;38%;18%;NA;NA;NA;NA;NA;NA;59;NA;62%;NA
42;24736837_Ogunneye;24736837;The Association Between Skilled Nursing Facility Care Quality and 30-Day Readmission Rates After Hospitalization for Heart Failure.;Ogunneye;2010;Survey;No;2014;603;20%;NA;NA;NA;603;NA;32%;22%;18%;8%;19%;61%;97%;23%;82%;NA;84;NA;37%;NA
125;25080512_Nunez;25080512;Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited.;Nunez;2011;Survey;No;2017;705;NA;NA;NA;16%;705;26%;80%;47%;NA;NA;41%;28%;60%;NA;44%;148;73;97;51%;48
126;25097621_Ruan;25097621;Cystatin C, N-terminal probrain natriuretic peptides and outcomes in acute heart failure with acute kidney injury in a 12-month follow-up: Insights into the cardiorenal syndrome.;Ruan;2011;Survey;No;2014;162;NA;NA;NA;28%;162;NA;41%;29%;46%;NA;31%;78%;52%;NA;62%;149;52;NA;54%;39
127;25150587_Takaya;25150587;Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure.;Takaya;2008;Survey;No;2014;371;NA;NA;NA;15%;371;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;73;NA;60%;36
16;25168191_Scrutinio;25168191;Renal Dysfunction and Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Mortality for Hospitalized Patients With Heart Failure.;Scrutinio;2009;Survey;Yes;2014;908;NA;NA;NA;27%;908;NA;50%;32%;33%;24%;35%;NA;NA;NA;NA;111;66;NA;77%;29
35;25188234_Fisher;25188234;Impact of COPD on the Mortality and Treatment of Patients Hospitalized With Acute Decompensated Heart Failure.;Fisher;2000;Survey;Yes;2015;9748;NA;8%;NA;35%;9748;29%;69%;39%;NA;NA;38%;NA;NA;NA;NA;143;76;89;44%;46
37;25200338_Fleming;25200338;Derivation and Validation of a 30-Day Heart Failure Readmission Model.;Fleming;2009;Survey;No;2014;3413;25%;NA;NA;NA;3413;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;74;NA;52%;50
36;25210973_Ogah;25210973;Short-term outcomes after hospital discharge in patients admitted with heart failure in abeokuta, Nigeria:data from the abeokuta heart Failure registry.;Ogah;2010;Survey;No;2014;285;NA;4%;NA;NA;285;NA;81%;13%;NA;7%;NA;NA;NA;NA;NA;132;60;96;53%;NA
274;25253620_Sugimoto;25253620;Prognostic Value of Serum Parathyroid Hormone Level in  Acute Decompensated Heart Failure.;Sugimoto;2010;Survey;No;2014;266;NA;NA;NA;24%;266;40%;76%;32%;NA;NA;NA;53%;41%;NA;25%;151;78;NA;48%;49
225;25438912_Caughey;25438912;Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).;Caughey;2008;Survey;Yes;2014;15461;NA;11%;NA;36%;15461;NA;56%;45%;47%;33%;NA;40%;72%;NA;65%;141;76;NA;48%;42
128;25469731_Aramburu_Bodas;25469731;Relationship between osteoprotegerin and mortality in decompensated heart failure with preserved ejection fraction.;Aramburu_Bodas;2010;Survey;No;2015;177;NA;NA;NA;24%;177;NA;88%;54%;20%;30%;52%;55%;NA;NA;38%;NA;76;NA;31%;59
17;25520409_AlHabib;25520409;Long-Term Mortality Rates in Acute De Novo Versus Acute-on-Chronic Heart Failure: From the Heart Function Assessment Registry Trial in Saudi Arabia.;AlHabib;2010;Survey;Yes;2015;2610;NA;8%;NA;20%;2610;NA;71%;64%;53%;NA;16%;NA;NA;NA;NA;129;61;89;66%;NA
129;25534479_de_Miguel_Yanes;25534479;First plasma glucose value after urgent admission and in-hospital mortality in acutely decompensated heart failure.;de_Miguel_Yanes;2011;Survey;Yes;2015;788;10%;NA;NA;NA;788;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;83;NA;37%;NA
18;25537794_Vorilhon;25537794;Heart failure prognosis and management in over-80-year-old patients: data from a French national observational retrospective cohort.;Vorilhon;2010;Survey;Yes;2015;1825;NA;NA;18%;NA;1825;NA;64%;28%;35%;12%;40%;NA;NA;NA;NA;NA;77;NA;48%;NA
43;25554369_Bhatia;25554369;Beta-Blocker Use and 30-Day All-Cause Readmission in Medicare Beneficiaries with Systolic Heart Failure;Bhatia;2000;Survey;Yes;2014;760;21%;4%;NA;NA;760;66%;72%;48%;NA;29%;23%;NA;NA;NA;NA;150;73;97;56%;27
130;25572328_Sud;25572328;Presentation blood glucose and death, hospitalization, and future diabetes risk in patients with acute heart failure syndromes.;Sud;2006;Survey;Yes;2015;16524;NA;8%;NA;NA;16524;NA;63%;NA;52%;22%;29%;56%;51%;19%;45%;141;79;87;49%;NA
41;25576679_Berra;25576679;Outcome in Acute Heart Failure: Prognostic Value of Acute Kidney Injury and Worsening Renal Function.;Berra;2008;Survey;No;2015;646;NA;NA;57%;30%;646;NA;NA;31%;43%;16%;48%;61%;59%;NA;41%;NA;80;NA;55%;NA
20;25588532_Sherazi;25588532;Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction >40%.;Sherazi;2003;Survey;No;2015;191;NA;NA;NA;25%;191;NA;73%;44%;49%;NA;31%;57%;90%;17%;68%;138;70;NA;40%;55
131;25636743_Khayat;25636743;Sleep disordered breathing and post-discharge mortality in patients with acute heart failure.;Khayat;2008;Survey;No;2015;1117;NA;3%;NA;16%;1117;NA;63%;41%;66%;NA;49%;NA;NA;NA;NA;NA;59;NA;72%;26
21;25642610_Ahmedani;25642610;Psychiatric comorbidity on 30-day readmissions for heart failure, myocardial infarction, and pneumonia.;Ahmedani;2010;Survey;Yes;2016;89406;20%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
22;25643435_Polat;25643435;The prognostic significance of serum albumin in patients with acute decompensated systolic heart failure.;Polat;2012;Survey;No;2017;135;NA;NA;NA;30%;135;NA;62%;38%;52%;NA;34%;NA;NA;NA;NA;122;67;94;54%;28
132;25662471_Caetano;25662471;Continuous infusion or bolus injection of loop diuretics for patients admitted for severe acute heart failure: is one strategy better than the other?;Caetano;2011;Survey;No;2014;110;NA;10%;NA;33%;110;NA;68%;31%;NA;NA;NA;NA;NA;NA;NA;120;69;NA;77%;32
227;25694226_Selim;25694226;Mortality and readmission rates in patients hospitalized for acute decompensated heart failure: a comparison between cardiology and general-medicine service outcomes in an underserved population.;Selim;2006;Survey;No;2015;7211;20%;4%;NA;NA;7516;NA;85%;55%;65%;NA;37%;58%;NA;NA;62%;140;71;82;45%;48
228;25724302_Huynh;25724302;Roles of nonclinical and clinical data in prediction of 30-day rehospitalization or death among heart failure patients.;Huynh;2010;Survey;No;2015;1537;19%;6%;NA;NA;977;0%;70%;35%;NA;37%;47%;74%;93%;22%;54%;123;80;78;50%;NA
133;25739882_Sulaiman;25739882;Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE).;Sulaiman;2012;Survey;Yes;2015;5005;NA;NA;NA;20%;5005;54%;61%;50%;47%;NA;12%;43%;58%;17%;44%;137;59;97;63%;35
19;25777937_Ohlmeier;25777937;Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons.;Ohlmeier;2005;Survey;Yes;2015;3395;NA;NA;NA;23%;3395;NA;55%;22%;24%;16%;25%;NA;NA;NA;NA;NA;NA;NA;70%;NA
134;25854896_Santas;25854896;Tricuspid Regurgitation and Mortality Risk Across Left Ventricular Systolic Function in Acute Heart Failure.;Santas;2008;Survey;No;2015;1842;NA;NA;NA;20%;1842;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;73;NA;49%;NA
226;25890356_Inouye;25890356;Predicting readmission of heart failure patients using automated follow-up calls.;Inouye;2011;Survey;No;2015;1095;22%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
135;25965613_Kajimoto;25965613;Association of age and baseline systolic blood pressure with outcomes in patients hospitalized for acute heart failure syndromes.;Kajimoto;2009;Survey;Yes;2015;4828;NA;NA;NA;17%;4828;NA;70%;34%;NA;12%;36%;48%;46%;13%;34%;145;73;98;58%;NA
325;25967111_Khan;25967111;Chloride Depletion Alkalosis as a Predictor of Inhospital Mortality in Patients with Decompensated Heart Failure.;Khan;2007;Survey;No;2014;674;NA;3%;NA;NA;674;96%;89%;39%;39%;NA;NA;50%;56%;NA;57%;138;65;91;51%;NA
136;25982671_Okayama;25982671;Thyroid function on admission and outcome in patients hospitalized for acute decompensated heart failure.;Okayama;2010;Survey;No;2015;270;NA;NA;NA;19%;270;NA;60%;41%;NA;11%;40%;45%;51%;22%;48%;136;67;93;69%;NA
269;26010223_Avaldi;26010223;Hospital Readmissions o fPatients with Heart Failure: The Impact of Hospital and Primary Care Organizational Factors in Northern Italy.;Avaldi;2010;Survey;Yes;2015;1873;16%;NA;93%;NA;1873;NA;26%;10%;NA;11%;NA;NA;NA;NA;NA;NA;NA;NA;44%;NA
137;26037295_Reynolds;26037295;Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality.;Reynolds;2010;Survey;Yes;2015;19927;21%;6%;60%;26%;19927;57%;86%;47%;45%;NA;NA;46%;47%;10%;50%;130;74;75;53%;NA
272;26096722_Lai;26096722;Comparison of management and outcomes of ED patients with acute decompensated heart failure between the Canadian and United States' setting.;Lai;2010;Survey;Yes;2016;321;19%;7%;NA;NA;321;61%;62%;46%;56%;21%;43%;41%;75%;NA;72%;136;76;85;53%;46
138;26150730_Palmer;26150730;Association of persistent and transient worsening renal function with mortality risk, readmissions risk, length of stay, and costs in patients hospitalized with acute heart failure;Palmer;2010;Survey;Yes;2015;55436;NA;7%;NA;9%;55436;NA;NA;NA;NA;NA;NA;43%;71%;NA;78%;NA;72;NA;47%;NA
48;26359710_Lee;26359710;Prognostic impact of preexisting hypertension and high systolic blood pressure at admission in patients hospitalized for systolic heart failure;Lee;2006;Survey;Yes;2015;3538;NA;NA;NA;8%;3538;NA;NA;34%;16%;5%;25%;NA;NA;NA;NA;130;67;93;56%;30
3;26364256_Baker;26364256;Regional Hospital Collaboration and Outcome in Medicare Heart Failure Patients.;Baker;2012;Survey;Yes;2015;237842;27%;NA;NA;NA;237842;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;44%;NA
139;26410603_Sharma;26410603;Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction.;Sharma;2012;Survey;No;2015;206;NA;NA;57%;13%;206;NA;89%;56%;18%;NA;25%;43%;74%;3%;56%;150;63;NA;38%;NA
140;26449993_Collins;26449993;Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool.;Collins;2009;Survey;Yes;2015;1015;NA;4%;NA;NA;1033;74%;82%;33%;NA;NA;NA;44%;69%;NA;66%;144;64;88;57%;NA
141;26506831_Fabbri;26506831;Acute heart failure in the emergency department: a follow-up study.;Fabbri;2012;Survey;Yes;2015;1234;NA;10%;NA;50%;1234;46%;NA;26%;NA;36%;NA;NA;NA;NA;NA;130;84;NA;44%;45
221;26519995_Costanzo;26519995;Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure.;Costanzo;2013;Trial;Yes;2016;213;31%;NA;NA;NA;221;100%;86%;63%;62%;33%;NA;29%;56%;14%;52%;122;67;78;71%;37
142;26539964_Behnes;26539964;Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.;Behnes;2006;Survey;No;2016;122;NA;NA;NA;20%;122;NA;80%;43%;NA;NA;NA;NA;NA;NA;NA;NA;73;NA;61%;39
143;26544063_Lourenco;26544063;Is there a heart rate paradox in acute heart failure?;Lourenco;2010;Survey;Yes;2015;564;NA;NA;NA;36%;564;NA;76%;41%;NA;NA;47%;NA;NA;20%;47%;131;78;NA;44%;NA
33;26678634_Cooper;26678634;Differences in health care use and outcomes by the timing of in-hospital worsening heart failure.;Cooper;2004;Survey;Yes;2015;62908;21%;10%;61%;36%;62908;NA;17%;41%;60%;30%;35%;49%;68%;NA;49%;146;80;87;43%;NA
7;26702083_Donaho;26702083;Protocol-Driven Allied Health Post-Discharge Transition Clinic to Reduce Hospital Readmissions in Heart Failure.;Donaho;2011;Survey;No;2015;114;12%;NA;NA;NA;114;NA;86%;56%;54%;23%;26%;NA;NA;NA;NA;NA;59;NA;48%;NA
144;26717213_Pourafkari;26717213;Predicting outcome in acute heart failure, does it matter?;Pourafkari;2008;Survey;No;2015;366;NA;19%;NA;NA;366;NA;59%;31%;45%;12%;NA;NA;NA;NA;NA;NA;68;NA;60%;NA
12;26729609_Kwan;26729609;Descriptive epidemiology and short-term outcome of heart failure hospitalisation in rural Haiti.;Kwan;2014;Survey;No;2016;274;7%;NA;NA;NA;311;NA;47%;8%;NA;NA;6%;NA;NA;NA;NA;142;53;108;40%;NA
8;26754527_Maggioni;26754527;The real-world evidence of heart failure : findings from 41413 patients of the ARNO database.;Maggioni;2010;Survey;Yes;2016;41413;NA;NA;57%;NA;41413;NA;NA;31%;NA;30%;NA;NA;NA;NA;NA;NA;78;NA;49%;NA
44;26767401_Llibre;26767401;The real-life value of ST2 monitoring during heart failure decompensation: impact on long-term readmission and mortality.;Llibre;2013;Survey;No;2016;182;NA;NA;NA;13%;182;55%;NA;NA;35%;NA;NA;NA;NA;NA;NA;NA;69;NA;65%;42
229;26840122_Ghith;26840122;Short Term Survival after Admission for Heart Failure in Sweden: Applying Multilevel Analyses of Discriminatory Accuracy to Evaluate Institutional Performance.;Ghith;2008;Survey;Yes;2016;36943;NA;9%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
230;26840627_Freedland;26840627;Depression and Multiple Rehospitalizations in Patients With Heart Failure.;Freedland;1996;Survey;No;2016;662;19%;NA;68%;18%;662;67%;NA;43%;NA;24%;NA;73%;NA;NA;18%;NA;66;NA;48%;35
231;26841333_Bress;26841333;Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.;Bress;2010;Survey;Yes;2016;989;NA;NA;34%;17%;989;100%;66%;39%;NA;NA;45%;53%;67%;NA;79%;115;65;82;7%;27
145;26857383_Ong;26857383;Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition - Heart Failure (BEAT-HF) Randomized Clinical Trial.;Ong;2012;Trial;Yes;2016;1437;22%;4%;NA;NA;1437;NA;81%;46%;NA;32%;NA;NA;NA;NA;NA;NA;73;NA;54%;43
326;26868921_Schmidt_(a);26868921;Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study.;Schmidt_(a);1985;Survey;Yes;2016;49158;NA;NA;NA;45%;49158;NA;7%;8%;NA;10%;5%;NA;NA;NA;NA;NA;76;NA;53%;NA
327;26868921_Schmidt_(b);26868921;Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study.;Schmidt_(b);2010;Survey;Yes;2016;46796;NA;NA;NA;33%;46796;NA;30%;15%;NA;16%;23%;NA;NA;NA;NA;NA;78;NA;56%;NA
146;26869641_Suzuki;26869641;Trimethylamine N-oxide and prognosis in acute heart failure.;Suzuki;2008;Survey;No;2016;972;NA;NA;NA;28%;972;NA;58%;34%;29%;9%;45%;NA;NA;NA;NA;133;78;88;61%;NA
47;26886619_Valbusa;26886619;Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure.;Valbusa;2014;Survey;No;2016;107;12%;NA;38%;NA;107;NA;NA;43%;37%;19%;51%;NA;NA;NA;NA;132;80;82;46%;50
297;26938187_Messina;26938187;Decreasing Congestive Heart Failure Readmission Rates Within 30 Days at the Tampa VA.;Messina;2012;Survey;Yes;2016;442;10%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA
298;26956954_Woodruff;26956954;Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.;Woodruff;2012;Survey;Yes;2016;131;31%;NA;NA;NA;131;NA;NA;47%;60%;21%;43%;NA;100%;NA;NA;NA;67;NA;64%;NA
4;26978568_Lee_(a);26978568;Post-Discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization.;Lee_(a);2010;Survey;Yes;2016;1587;100%;NA;NA;NA;1587;13%;86%;44%;13%;NA;44%;47%;59%;16%;66%;NA;76;NA;51%;NA
5;26978568_Lee_(b);26978568;Post-Discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization.;Lee_(b);2010;Survey;Yes;2016;7935;0%;NA;NA;NA;7935;8%;85%;41%;10%;NA;40%;43%;51%;12%;65%;NA;74;NA;50%;NA
147;27004966_Oguri;27004966;Clinical characteristics of patients hospitalized for acute heart failure according to hospital arrival timing.;Oguri;2012;Survey;No;2016;679;NA;6%;NA;NA;679;NA;61%;32%;NA;NA;32%;NA;NA;NA;NA;158;77;100;57%;NA
6;27028590_Dordunoo;27028590;Inpatient Unit Heart Failure Discharge Volume Predicts All-cause 30-Day Hospital Readmission.;Dordunoo;2011;Survey;Yes;2016;425;20%;NA;NA;NA;425;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;121;62;79;48%;38
148;27030541_Nunez;27030541;Iron deficiency and risk of early readmission following a hospitalization for acute heart failure.;Nunez;2014;Survey;No;2016;626;16%;3%;NA;NA;626;77%;64%;52%;39%;24%;44%;NA;NA;NA;NA;144;73;94;52%;NA
34;27114058_Davison;27114058;Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.;Davison;2008;Trial;Yes;2016;1849;20%;2%;NA;NA;1849;97%;80%;46%;69%;NA;53%;NA;NA;NA;NA;125;70;80;67%;NA
149;27121354_Muhlestein;27121354;Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30-day outcomes;Muhlestein;2008;Survey;Yes;2016;6414;7%;15%;NA;NA;6414;NA;NA;44%;27%;24%;NA;47%;95%;26%;67%;NA;79;NA;50%;NA
150;27145910_Gouda;27145910;Insights into the importance of the electrocardiogram in patients with acute heart failure.;Gouda;2010;Survey;Yes;2016;816;NA;NA;NA;27%;816;NA;76%;38%;53%;NA;52%;49%;91%;11%;68%;134;77;84;54%;NA
328;27393709_Shulenberger;27393709;Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.;Shulenberger;2010;Survey;No;2016;177;19%;NA;NA;NA;177;NA;NA;NA;NA;NA;NA;38%;82%;27%;57%;NA;59;NA;54%;36
29;27468707_Murtaugh;27468707;Reducing Readmissions among Heart Failure Patients Discharged to Home Health Care: Effectiveness of Early and Intensive Nursing Services and Early Physician Follow-Up.;Murtaugh;2010;Survey;Yes;2017;98730;21%;1%;NA;NA;98730;NA;NA;33%;NA;34%;56%;NA;NA;NA;NA;NA;80;NA;40%;NA
151;27469321_Okuhara;27469321;Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.;Okuhara;2012;Survey;No;2016;175;7%;NA;37%;15%;175;NA;71%;38%;NA;NA;NA;51%;57%;NA;52%;136;72;86;71%;40
23;27488755_Avci;27488755;Relation between serum sodium levels and clinical outcomes in Turkish patients hospitalized for heart failure: a multi-center retrospective observational study.;Avci;2012;Survey;Yes;2015;487;NA;NA;NA;5%;487;NA;NA;13%;61%;NA;NA;NA;NA;NA;NA;128;65;82;70%;30
285;27561195_MacDonald;27561195;Comparison of Characteristics and Outcomes of Heart Failure Patients With Preserved Versus Reduced Ejection Fraction in a Multiethnic Southeast Asian Cohort.;MacDonald;2011;Survey;No;2016;1978;NA;NA;63%;15%;1978;NA;73%;52%;69%;10%;25%;NA;NA;NA;NA;143;69;92;58%;NA
30;27590209_Claret;27590209;Characteristics and outcomes for acute heart failure in elderly patients presenting to the ED.;Claret;2010;Survey;Yes;2016;1147;NA;4%;NA;NA;1658;73%;70%;40%;33%;22%;39%;44%;74%;13%;44%;141;77;84;46%;NA
46;27592085_Davis;27592085;All-Payer Analysis of Heart Failure Hospitalization 30-Day Readmission: Comorbidities Matter.;Davis;2009;Survey;Yes;2017;547068;21%;NA;NA;NA;547068;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;75;NA;49%;NA
152;27611369_Teixeira;27611369;Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients.;Teixeira;2012;Survey;No;2016;101;NA;NA;NA;18%;101;51%;56%;31%;NA;5%;NA;63%;64%;NA;52%;135;73;86;65%;NA
222;27631119_Dunlay;27631119;Patient Activation in Acute Decompensated Heart Failure.;Dunlay;2014;Survey;Yes;2017;302;21%;7%;NA;NA;302;NA;83%;45%;NA;27%;NA;NA;NA;NA;NA;NA;77;NA;57%;NA
153;27631204_Laborde_Casterot;27631204;Effectiveness of a multidisciplinary heart failure disease management programme on 1-year mortality Prospective cohort study.;Laborde_Casterot;2012;Survey;Yes;2016;1816;NA;NA;NA;21%;1816;NA;NA;36%;NA;23%;NA;NA;NA;NA;NA;NA;77;NA;49%;45
223;27654854_Felker;27654854;Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure.;Felker;2014;Trial;Yes;2017;257;NA;6%;NA;NA;257;NA;NA;55%;56%;NA;52%;61%;NA;NA;90%;118;65;80;66%;33
154;27701482_Chacha_Mwita;27701482;Presentation and mortality of patients hospitalised with acute heart failure in Botswana.;Chacha_Mwita;2014;Survey;No;2017;190;NA;15%;NA;NA;193;NA;55%;16%;NA;NA;10%;NA;NA;NA;NA;120;54;95;54%;42
155;27709804_Biegus;27709804;Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.;Biegus;2012;Survey;No;2016;203;NA;NA;NA;33%;203;81%;NA;NA;NA;NA;NA;NA;NA;NA;NA;126;65;89;76%;NA
156;27758007_Breidthardt;27758007;Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function.;Breidthardt;2007;Survey;No;2017;1019;NA;NA;NA;29%;1019;NA;73%;31%;NA;25%;NA;37%;54%;NA;51%;138;79;92;55%;45
45;27761738_Omersa;27761738;Mortality and readmissions in heart failure: an analysis of 36,824 elderly patients from the Slovenian national hospitalization database.;Omersa;2010;Survey;Yes;2016;29510;12%;5%;32%;25%;36824;NA;60%;23%;22%;8%;38%;NA;NA;NA;NA;NA;NA;NA;NA;NA
157;27774258_Schefold;27774258;Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.;Schefold;2002;Survey;No;2015;618;NA;6%;NA;27%;618;NA;44%;33%;22%;17%;52%;78%;83%;37%;48%;129;73;113;49%;43
158;27782093_De_Vecchis;27782093;Effects of Hyponatremia Normalization on the Short-Term Mortality and Rehospitalizations in Patients with Recent Acute Decompensated Heart Failure: A Retrospective Study.;De_Vecchis;2014;Survey;Yes;2016;160;26%;6%;NA;NA;160;NA;51%;32%;45%;18%;28%;NA;NA;NA;NA;110;77;96;51%;40
289;27791272_Chung;27791272;Evaluation of the predictors of readmission in Korean patients with heart failure.;Chung;2013;Survey;Yes;2017;19128;28%;NA;NA;NA;19128;NA;88%;58%;53%;46%;20%;44%;55%;15%;39%;NA;70;NA;47%;NA
9;27797432_Martin_Sanchez;27797432;The Effect of Frailty on 30-day Mortality Risk in Older Patients With Acute Heart Failure Attended in the Emergency Department..;Martin_Sanchez;2012;Survey;Yes;2017;465;NA;7%;NA;NA;465;63%;89%;37%;33%;22%;61%;NA;NA;NA;NA;NA;82;NA;39%;NA
159;27818784_Sotiropoulos;27818784;Red cell distribution width and mortality in acute heart failure patients with preserved and reduced ejection fraction.;Sotiropoulos;2011;Survey;No;2016;402;NA;NA;NA;28%;402;63%;85%;40%;NA;15%;NA;41%;56%;14%;39%;139;78;91;58%;46
160;27873502_Yang;27873502;Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.;Yang;2012;Trial;Yes;2016;180;40%;2%;NA;NA;180;NA;100%;50%;29%;NA;28%;53%;64%;27%;41%;NA;77;NA;58%;37
161;27912923_Marchetti;27912923;Predictors of 30-day mortality in patients admitted to ED for acute heart failure.;Marchetti;2014;Survey;No;2017;322;NA;18%;NA;NA;322;89%;75%;30%;33%;14%;54%;NA;NA;NA;NA;NA;84;NA;47%;NA
284;27914696_La_Rovere;27914696;Additional predictive value of nutritional status in the prognostic assessment of heart failure patients.;La_Rovere;2009;Survey;No;2017;466;NA;NA;NA;8%;466;NA;NA;27%;NA;21%;NA;NA;NA;NA;NA;113;61;NA;86%;34
162;27983996_Mueller;27983996;Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.;Mueller;2004;Survey;No;2016;137;NA;NA;NA;30%;137;47%;63%;29%;59%;NA;47%;NA;NA;NA;NA;135;76;86;93%;40
330;28011188_Gomez_Otero;28011188;Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure.;Gomez_Otero;2014;Survey;Yes;2016;1420;NA;6%;NA;20%;1420;57%;77%;47%;NA;17%;NA;NA;NA;NA;NA;134;72;89;62%;NA
163;28017303_Rothberger;28017303;Usefulness of Serum Triiodothyronine (T3) to Predict Outcomes in Patients Hospitalized With Acute Heart Failure.;Rothberger;2013;Survey;No;2017;137;20%;NA;NA;NA;137;NA;83%;45%;NA;12%;NA;NA;NA;NA;NA;NA;75;NA;55%;40
164;28126381_Miro;28126381;The effect of a short-stay unit on hospital admission and length of stay in acute heart failure: REDUCE-AHF study.;Miro;2010;Survey;Yes;2017;5543;NA;3%;NA;NA;5767;63%;84%;43%;30%;26%;48%;57%;69%;18%;37%;NA;NA;NA;44%;NA
165;28154584_Youn_(a);28154584;Temporal Trends of Hospitalized Patients with Heart Failure in Korea.;Youn_(a);1992;Survey;Yes;2017;1657;NA;NA;NA;18%;1657;NA;40%;20%;NA;NA;9%;NA;NA;NA;NA;NA;64;NA;43%;NA
166;28154584_Youn_(b);28154584;Temporal Trends of Hospitalized Patients with Heart Failure in Korea.;Youn_(b);2000;Survey;Yes;2017;1759;NA;NA;NA;20%;1759;NA;30%;26%;NA;NA;27%;NA;NA;NA;NA;NA;64;NA;53%;NA
167;28154584_Youn_(c);28154584;Temporal Trends of Hospitalized Patients with Heart Failure in Korea.;Youn_(c);2006;Survey;Yes;2017;3200;NA;NA;NA;15%;3200;NA;47%;31%;NA;NA;22%;NA;NA;NA;NA;NA;68;NA;50%;NA
283;28183728_Suzuki;28183728;Prognostic Role of Molecular Forms of B-Type Natriuretic Peptide in Acute Heart Failure.;Suzuki;2008;Survey;No;2017;838;NA;NA;NA;27%;838;66%;58%;34%;27%;10%;NA;NA;NA;NA;NA;133;78;88;61%;NA
286;28221672_Bandle;28221672;Can Braden Score Predict Outcomes for Hospitalized Heart Failure Patients?;Bandle;2012;Survey;No;2017;642;16%;4%;NA;NA;642;NA;NA;37%;NA;30%;NA;NA;NA;NA;NA;NA;62;NA;59%;NA
233;28238219_Alvarez;28238219;Prevalence of in-hospital nonsteroidal antiinflammatory drug exposure in patients with a primary diagnosis of heart failure.;Alvarez;2012;Survey;No;2017;9742;21%;NA;NA;NA;9742;NA;NA;47%;NA;45%;38%;NA;NA;NA;NA;137;70;81;53%;NA
168;28262195_Bonilla_Palomas;28262195;Nutritional Intervention in Malnourished Hospitalized Patients with Heart Failure.;Bonilla_Palomas;2014;Trial;Yes;2016;120;NA;NA;NA;34%;120;65%;75%;48%;NA;15%;NA;73%;NA;NA;62%;131;79;80;38%;49
299;28277275_Cox;28277275;Association between health literacy and 30-day healthcare use after hospital discharge in the heart failure population.;Cox;2011;Survey;No;2016;264;32%;NA;NA;NA;264;NA;70%;44%;34%;19%;NA;NA;NA;NA;NA;NA;NA;NA;58%;NA
169;28302292_Konstam;28302292;Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.;Konstam;2014;Trial;Yes;2017;250;NA;5%;NA;NA;250;100%;NA;60%;NA;NA;40%;56%;NA;NA;92%;122;68;NA;67%;34
236;28318656_Bonsu;28318656;Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients.;Bonsu;2011;Survey;No;2017;1488;NA;NA;NA;10%;1488;NA;61%;23%;10%;2%;21%;NA;NA;NA;NA;134;60;71;46%;53
237;28320381_Korda;28320381;Variation in readmission and mortality following hospitalisation with a diagnosis of heart failure: prospective cohort study using linked data.;Korda;2007;Survey;Yes;2017;5074;21%;4%;NA;NA;5074;23%;NA;24%;NA;NA;28%;NA;NA;NA;NA;NA;80;NA;58%;NA
170;28406038_Miro;28406038;The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure.;Miro;2014;Survey;No;2017;115;NA;6%;NA;37%;115;57%;82%;41%;27%;32%;48%;NA;NA;NA;NA;150;79;92;51%;46
24;28420549_Cho;28420549;Predictors of Left Ventricular Functional Recovery and Their Impact on Clinical Outcomes in Patients With Newly Diagnosed Dilated Cardiomyopathy and Heart Failure.;Cho;2010;Survey;No;2017;175;NA;NA;NA;17%;175;NA;33%;26%;NA;NA;24%;NA;NA;NA;NA;124;59;86;63%;NA
25;28420862_Ostrega;28420862;Clinical characteristics, treatment, and prognosis of patients with ischemic and nonischemic acute severe heart failure.;Ostrega;2012;Survey;No;2017;112;NA;NA;NA;31%;112;NA;52%;42%;NA;7%;42%;NA;NA;NA;NA;108;58;87;75%;24
26;28457798_Tabit;28457798;Cardiology Consultation in the Emergency Department Reduces Re-hospitalizations for Low-Socioeconomic Patients with Acute Decompensated Heart Failure.;Tabit;2015;Trial;No;2017;784;19%;NA;NA;NA;784;NA;77%;30%;39%;NA;30%;47%;68%;NA;59%;117;65;81;53%;37
171;28459958_Pang;28459958;Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).;Pang;2014;Trial;Yes;2017;618;NA;4%;NA;NA;618;98%;84%;44%;66%;17%;55%;79%;NA;NA;86%;134;70;79;62%;36
172;28463462_Chioncel;28463462;Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.;Chioncel;2013;Survey;Yes;2017;6629;NA;NA;44%;27%;6629;71%;NA;39%;NA;19%;30%;NA;NA;NA;NA;130;NA;88;63%;39
173;28484958_Doering;28484958;Markers of diuretic resistance in emergency department patients with acute heart failure.;Doering;2012;Survey;No;2017;187;NA;4%;NA;NA;187;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;149;64;NA;65%;NA
174;28496020_Jin;28496020;Predictors of Long-Term Mortality in Patients With Acute Heart Failure,;Jin;2014;Survey;No;2017;270;NA;NA;NA;17%;287;NA;48%;20%;NA;NA;29%;82%;93%;43%;80%;126;61;84;63%;39
31;28501521_Sud;28501521;Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure.;Sud;2008;Survey;Yes;2017;58230;NA;4%;NA;NA;58230;65%;87%;45%;35%;15%;24%;61%;53%;17%;49%;NA;NA;NA;50%;NA
32;28501527_Ziaeian;28501527;Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction.;Ziaeian;2010;Survey;Yes;2017;51543;22%;6%;67%;33%;53065;NA;81%;39%;45%;NA;44%;29%;61%;NA;55%;144;82;79;34%;60
175;28506551_Turcato;28506551;Early in-hospital variation of red blood cell distribution width predicts mortality in patients with acute heart failure,;Turcato;2015;Survey;No;2017;588;NA;15%;NA;NA;588;NA;96%;31%;88%;35%;23%;53%;65%;NA;46%;NA;83;NA;54%;NA
300;28522164_Kingery;28522164;Heart Failure. Post-Hospital Mortality and Renal Function in Tanzania: a prospective cohort study.;Kingery;2014;Survey;No;2017;107;NA;NA;NA;58%;145;NA;42%;10%;NA;NA;NA;NA;NA;NA;NA;125;52;93;44%;NA
301;28528982_Casado_(a);28528982;Influence of renal dysfunction phenotype onmortality in decompensated heart failure with preserved and mid-range ejection fraction.;Casado_(a);2008;Survey;Yes;2017;508;NA;NA;NA;23%;508;NA;84%;45%;NA;26%;60%;NA;NA;NA;NA;139;81;83;37%;60
302;28528982_Casado_(b);28528982;Influence of renal dysfunction phenotype onmortality in decompensated heart failure with preserved and mid-range ejection fraction.;Casado_(b);2008;Survey;Yes;2017;153;NA;NA;NA;27%;153;NA;89%;58%;NA;26%;56%;NA;NA;NA;NA;138;79;82;60%;45
176;28567084_Lee;28567084;Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF).;Lee;2012;Survey;Yes;2017;5356;NA;3%;NA;18%;5625;48%;62%;40%;43%;NA;28%;38%;NA;NA;28%;131;69;93;53%;38
331;28579091_Marques;28579091;Characteristics and outcomes of heart failure hospitalization before implementation of a heart failure clinic: The PRECIC study.;Marques;2012;Survey;No;2017;394;NA;NA;NA;34%;429;NA;87%;48%;NA;28%;52%;NA;NA;NA;NA;140;79;NA;38%;NA
177;28580623_Herrero_Puente;28580623;The relationship of circulating relaxin-2 concentrations with short-term prognosis in patients with acute heart failure: the RELAHF study.;Herrero_Puente;2014;Survey;Yes;2017;522;NA;8%;NA;NA;522;60%;83%;39%;33%;20%;51%;26%;64%;15%;35%;143;81;90;46%;NA
332;28586100_Sommerfeld;28586100;Obstructive Sleep Apnea Is Associated With Increased Readmission in Heart Failure Patients.;Sommerfeld;2014;Survey;No;2017;344;23%;NA;NA;NA;344;NA;NA;55%;72%;38%;46%;NA;NA;NA;NA;NA;72;76;99%;40
178;28595171_Shen;28595171;Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients.;Shen;2014;Survey;No;2017;161;NA;NA;NA;26%;161;NA;41%;18%;19%;NA;27%;NA;NA;NA;NA;124;59;82;63%;43
179;28625377_Harikrishnan;28625377;One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India,;Harikrishnan;2014;Survey;Yes;2017;1205;NA;NA;28%;31%;1205;NA;58%;55%;NA;15%;15%;NA;NA;NA;NA;129;61;NA;69%;NA
180;28626112_Kiuchi;28626112;Experience with long-term administration of tolvaptan to patients with acute decompensated heart failure.;Kiuchi;2013;Trial;No;2017;209;NA;NA;NA;28%;209;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;73;NA;52%;NA
329;28637595_Escobar;28637595;A one-year mortality clinical prediction rule for patients with heart failure.;Escobar;2011;Survey;Yes;2017;2565;NA;NA;NA;24%;2565;NA;NA;NA;NA;29%;NA;NA;NA;NA;NA;137;77;NA;50%;50
27;28648393_Arora;28648393;Etiologies, Trends, and Predictors of 30-Day Readmissions in Patients With Diastolic Heart Failure.;Arora;2014;Survey;Yes;2017;192394;21%;NA;NA;NA;192394;NA;80%;43%;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;38%;NA
232;28682895_Castello;28682895;Acute decompensated heart failure in the emergency department: Identification of early predictors of outcome.;Castello;2013;Survey;No;2017;530;18%;9%;NA;NA;530;NA;69%;33%;NA;32%;48%;NA;NA;NA;NA;NA;82;85;45%;NA
28;28697926_Leon_Gonzalez;28697926;Health Literacy and Health Outcomes in Very Old Patients With Heart Failure.;Leon_Gonzalez;2011;Survey;Yes;2017;556;NA;NA;NA;34%;556;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;86;NA;38%;NA
275;28719692_Dharmarajan_( a );28719692;Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge.;Dharmarajan_( a );2008;Survey;Yes;2017;449135;24%;8%;NA;NA;449135;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;81;NA;45%;NA
276;28719692_Dharmarajan_( b );28719692;Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge.;Dharmarajan_( b );2009;Survey;Yes;2017;450536;24%;8%;NA;NA;450536;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;81;NA;45%;NA
277;28719692_Dharmarajan_( c );28719692;Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge.;Dharmarajan_( c );2010;Survey;Yes;2017;441674;23%;8%;NA;NA;441674;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;81;NA;46%;NA
278;28719692_Dharmarajan_( d );28719692;Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge.;Dharmarajan_( d );2011;Survey;Yes;2017;425890;23%;9%;NA;NA;425890;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;81;NA;46%;NA
279;28719692_Dharmarajan_( e );28719692;Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge.;Dharmarajan_( e );2012;Survey;Yes;2017;410057;23%;9%;NA;NA;410057;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;81;NA;46%;NA
280;28719692_Dharmarajan_( f );28719692;Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge.;Dharmarajan_( f );2013;Survey;Yes;2017;400040;22%;9%;NA;NA;400040;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;81;NA;46%;NA
281;28719692_Dharmarajan_( g );28719692;Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge.;Dharmarajan_( g );2014;Survey;Yes;2017;385222;21%;9%;NA;NA;385222;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;81;NA;46%;NA
282;28755175_Bottle;28755175;Regional variation in hospitalisation and mortality in heart failure: comparison of England and Lombardy using multistate modelling.;Bottle;2010;Survey;Yes;2017;271904;5%;NA;NA;38%;271904;NA;48%;NA;NA;22%;NA;NA;NA;NA;NA;NA;78;NA;50%;NA
10;28772186_Deek;28772186;An evaluation of involving family caregivers in the self-care of heart failure patients on hospital readmission : Randomised controlled trial (the Family study).;Deek;2014;Trial;Yes;2017;256;12%;11%;NA;NA;256;68%;72%;46%;65%;18%;32%;NA;NA;NA;NA;123;67;NA;55%;36
181;28776539_Wang;28776539;Characteristics, Management, and Outcomes of Acute Heart Failure in the Emergency Department: A Multicenter Registry Study with 1-year Follow-up in a Chinese Cohort in Beijing.;Wang;2012;Survey;Yes;2017;3049;16%;15%;47%;32%;3049;50%;42%;30%;NA;NA;28%;NA;NA;NA;NA;130;71;96;53%;44
11;28801153_Fernandez_Gasso;28801153;Trends, causes and timing of 30-day readmissions after hospitalization for heart failure : 11-year population-based analysis with linked data.;Fernandez_Gasso;2008;Survey;Yes;2017;24654;20%;NA;NA;NA;27158;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;77;NA;43%;NA
182;28826899_Martin_Sanchez;28826899;Impact of Frailty and Disability on 30-Day Mortality in Older Patients With Acute Heart Failure;Martin_Sanchez;2012;Survey;Yes;2017;596;NA;12%;NA;NA;596;63%;89%;37%;30%;23%;60%;32%;NA;17%;18%;NA;83;NA;39%;NA
183;28883217_Uemura;28883217;Safety and Efficacy of Long-Term Use of Tolvaptan in Patients With Heart Failure and Chronic Kidney Disease.;Uemura;2014;Survey;No;2017;99;NA;NA;NA;11%;102;64%;66%;46%;48%;NA;51%;45%;93%;NA;70%;116;74;79;60%;NA
184;28885958_Lin;28885958;Repeat Hospitalizations Predict Mortality in Patients With Heart Failure.;Lin;2009;Survey;Yes;2017;51286;NA;7%;NA;27%;51286;0%;93%;53%;73%;NA;47%;NA;NA;NA;NA;NA;76;NA;55%;NA
185;28890872_Thawabi;28890872;Cardiac troponin and outcome in decompensated heart failure with preserved ejection fraction.;Thawabi;2012;Survey;No;2017;363;NA;3%;NA;9%;363;NA;87%;52%;35%;NA;30%;NA;NA;NA;NA;NA;73;NA;37%;58
186;28910238_Dadosky;28910238;Telemanagement of Heart Failure Patients Across the Post-Acute Care Continuum.;Dadosky;2012;Survey;No;2017;141;22%;NA;NA;NA;141;69%;NA;40%;NA;35%;NA;NA;NA;NA;NA;129;80;77;74%;NA
187;28948683_Koh;28948683;A comprehensive population-based characterization of heart failure with mid-range ejection fraction.;Koh;2006;Survey;Yes;2017;35079;NA;3%;NA;16%;41701;NA;60%;27%;51%;NA;55%;NA;NA;NA;NA;NA;74;NA;63%;NA
188;28948688_van_Boven;28948688;Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure;van_Boven;2011;Survey;Yes;2017;456;NA;NA;NA;25%;456;20%;50%;37%;48%;NA;43%;NA;NA;NA;NA;125;73;85;63%;30
189;28956134_Shirakabe;28956134;Prognostic benefit of maintaining the hemoglobin level during the acute phase in patients with severely decompensated acute heart failure.;Shirakabe;2008;Survey;No;2017;1109;NA;NA;NA;42%;1109;33%;73%;44%;NA;NA;NA;NA;NA;NA;NA;158;74;111;66%;35
190;28982652_van_den_Berge;28982652;Short- and Long-term Prognosis of Patients With Acute Heart Failure With and Without Diabetes: Changes Over the Last Three Decades.;van_den_Berge;1996;Survey;No;2017;1810;NA;15%;NA;NA;1810;49%;33%;21%;NA;NA;22%;NA;NA;NA;NA;NA;64;NA;64%;NA
191;29124524_Formiga;29124524;High comorbidity, measured by the Charlson Comorbidity Index, associates with higher 1-year mortality risks in elderly patients experiencing a first acute heart failure hospitalization.;Formiga;2014;Survey;No;2017;897;NA;10%;NA;27%;897;0%;86%;38%;24%;22%;38%;NA;NA;NA;NA;138;80;87;43%;NA
287;29148301_Geva;29148301;Provider Connectedness to Other Providers Reduces Risk of Readmission After Hospitalization for Heart Failure.;Geva;2010;Survey;Yes;2017;1347;25%;NA;NA;NA;1347;NA;86%;44%;NA;20%;NA;NA;NA;NA;NA;NA;54;NA;60%;NA
192;29154416_Buggey;29154416;Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization.;Buggey;2008;Survey;No;2017;463;7%;3%;14%;21%;463;NA;95%;60%;66%;18%;53%;65%;NA;NA;82%;130;69;NA;38%;NA
293;29191505_Wang;29191505;Predictors of Frequent Readmissions in Patients With Heart Failure.;Wang;2006;Survey;Yes;2017;6252;NA;NA;42%;17%;6252;NA;59%;26%;59%;NA;39%;NA;NA;NA;NA;NA;80;NA;52%;NA
193;29265710_Al_Omary;29265710;Outcomes following heart failure hospitalization in a regional Australian setting between 2005 and 2014.;Al_Omary;2010;Survey;Yes;2017;10840;20%;13%;58%;32%;12114;NA;43%;23%;28%;20%;31%;NA;NA;NA;NA;NA;80;NA;49%;NA
194;29622977_Abdellah;29622977;Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure.;Abdellah;2012;Survey;No;2017;120;NA;8%;NA;NA;120;NA;35%;43%;73%;6%;NA;NA;NA;NA;NA;124;59;NA;56%;NA